Boles, A., Kandimalla, R., & Reddy, P. H. (2017). Dynamics of diabetes and obesity: epidemiological perspective. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1863(5), 1026–1036.
Chen, J.-C., Hsu-Chou, H., Lu, J.-L., Chiang, Y.-C., Huang, H.-M., Wang, H.-L., Wu, T., Liao, J.-J., & Yeh, T.-S. (2005). Down-regulation of the glial glutamate transporter GLT-1 in rat hippocampus and striatum and its modulation by a group III metabotropic glutamate receptor antagonist following transient global forebrain ischemia. Neuropharmacology, 49(5), 703–714.
Classics Lowry, O., Rosebrough, N., Farr, A., & Randall, R. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193, 265–275.
Ferreira, L. S. S., Fernandes, C. S., Vieira, M. N. N., & De Felice, F. G. (2018). Insulin resistance in Alzheimer’s disease. Frontiers in Neuroscience, 12, 830.
Füllgrabe, J., Lynch-Day, M. A., Heldring, N., Li, W., Struijk, R. B., Ma, Q., Hermanson, O., Rosenfeld, M. G., Klionsky, D. J., & Joseph, B. (2013). The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature, 500(7463), 468–471.
Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J., & Sabatini, D. M. (2006). Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKC$α$, but not S6K1. Developmental Cell, 11(6), 859–871.
J Spielman, L., Bahniwal, M., P Little, J., G Walker, D., & Klegeris, A. (2015). Insulin modulates in vitro secretion of cytokines and cytotoxins by human glial cells. Current Alzheimer Research, 12(7), 684–693.
Jahn, H. (2013). Memory loss in Alzheimer’s disease. Dialogues in Clinical Neuroscience, 15(4), 445.
K C, S., Kakoty, V., Venkata Krishna, K., Kumar Dubey, S., Chitkara, D., & Taliyan, R. (2021). Neuroprotective Efficacy of Co-Encapsulated Rosiglitazone and Vorinostat Nanoparticle on Streptozotocin Induced Mice Model of Alzheimer Disease. ACS Chemical Neuroscience, 0(0). https://doi.org/10.1021/acschemneuro.1c00022
Khan, M., Rutten, B. P. F., & Kim, M. O. (2019). MST1 regulates neuronal cell death via JNK/Casp3 signaling pathway in HFD mouse brain and HT22 cells. International Journal of Molecular Sciences, 20(10), 2504.
Krishna, K. V., Saha, R. N., & Dubey, S. K. (2020). Biophysical, Biochemical, and Behavioral Implications of ApoE3 Conjugated Donepezil Nanomedicine in a A$β$1--42 Induced Alzheimer’s Disease Rat Model. ACS Chemical Neuroscience, 11(24), 4139–4151.
Labandeira-Garcia, J. L., Costa-Besada, M. A., Labandeira, C. M., Villar-Cheda, B., & Rodr\’\iguez-Perez, A. I. (2017). Insulin-like growth factor-1 and neuroinflammation. Frontiers in Aging Neuroscience, 9, 365.
Lu, Z., Liu, F., Chen, L., Zhang, H., Ding, Y., Liu, J., Wong, M., & Zeng, L.-H. (2015). Effect of chronic administration of low dose rapamycin on development and immunity in young rats. PloS One, 10(8), e0135256.
M Ashraf, G., H Greig, N., A Khan, T., Hassan, I., Tabrez, S., Shakil, S., A Sheikh, I., K Zaidi, S., Akram, M., R Jabir, N., & others. (2014). Protein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 13(7), 1280–1293.
Marques, S., & Outeiro, T. F. (2013). Epigenetics in Parkinson’s and Alzheimer’s diseases. In Epigenetics: Development and Disease (pp. 507–525). Springer.
Meng, J., Li, Y., Camarillo, C., Yao, Y., Zhang, Y., Xu, C., & Jiang, L. (2014). The anti-tumor histone deacetylase inhibitor SAHA and the natural flavonoid curcumin exhibit synergistic neuroprotection against amyloid-beta toxicity. PLoS One, 9(1), e85570.
Mizushima, N. (2010). The role of the Atg1/ULK1 complex in autophagy regulation. Current Opinion in Cell Biology, 22(2), 132–139.
Morris, R. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods, 11(1), 47–60.
Mullins, R. J., Diehl, T. C., Chia, C. W., & Kapogiannis, D. (2017). Insulin resistance as a link between amyloid-beta and tau pathologies in Alzheimer’s disease. Frontiers in Aging Neuroscience, 9, 118.
Ozansoy, M., Ozansoy, M. B., Yulug, B., Cankaya, S., Kilic, E., Goktekin, S., & Kilic, U. (2020). Melatonin affects the release of exosomes and tau-content in in vitro amyloid-beta toxicity model. Journal of Clinical Neuroscience, 73, 237–244.
Sarathlal, K. C., Kakoty, V., Marathe, S., Chitkara, D., & Taliyan, R. (2020). Exploring the Neuroprotective Potential of Rosiglitazone Embedded Nanocarrier System on Streptozotocin Induced Mice Model of Alzheimer’s Disease. Neurotoxicity Research, 1–16.
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005). Growing roles for the mTOR pathway. Current Opinion in Cell Biology, 17(6), 596–603.
Schotta, G., Lachner, M., Sarma, K., Ebert, A., Sengupta, R., Reuter, G., Reinberg, D., & Jenuwein, T. (2004). A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes & Development, 18(11), 1251–1262.
Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., & others. (2009). Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science, 326(5949), 140–144.
Sharma, S., & Taliyan, R. (2014). Neuroprotective role of Indirubin-3′-monoxime, a GSK$β$ inhibitor in high fat diet induced cognitive impairment in mice. Biochemical and Biophysical Research Communications, 452(4), 1009–1015.
Sharma, S., & Taliyan, R. (2015). Synergistic effects of GSK-3$β$ and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats. Naunyn-Schmiedeberg’s Archives of Pharmacology, 388(3), 337–349.
Sharma, S., & Taliyan, R. (2016). Epigenetic modifications by inhibiting histone deacetylases reverse memory impairment in insulin resistance induced cognitive deficit in mice. Neuropharmacology, 105, 285–297.
Sharma, S., & Taliyan, R. (2018). High fat diet feeding induced insulin resistance exacerbates 6-OHDA mediated neurotoxicity and behavioral abnormalities in rats. Behavioural Brain Research, 351, 17–23.
Sharma, S., Taliyan, R., & Ramagiri, S. (2015). Histone deacetylase inhibitor, trichostatin A, improves learning and memory in high-fat diet-induced cognitive deficits in mice. Journal of Molecular Neuroscience, 56(1), 1–11.
Sharma, S., Taliyan, R., & Singh, S. (2015). Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity. Behavioural Brain Research, 291, 306–314.
Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., & Galvan, V. (2010). Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-$β$ levels in a mouse model of Alzheimer’s disease. PloS One, 5(4), e9979.
Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C. L., & Ramarao, P. (2005). Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research, 52(4), 313–320.
Wend, P., Fang, L., Zhu, Q., Schipper, J. H., Loddenkemper, C., Kosel, F., Brinkmann, V., Eckert, K., Hindersin, S., Holland, J. D., & others. (2013). Wnt/$β$-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours. The EMBO Journal, 32(14), 1977–1989.
Yang, Y., Wu, Y., Zhang, S., & Song, W. (2013). High glucose promotes A$β$ production by inhibiting APP degradation. PloS One, 8(7), e69824.
Zeng, Z., Sarbassov, D. D., Samudio, I. J., Yee, K. W. L., Munsell, M. F., Ellen Jackson, C., Giles, F. J., Sabatini, D. M., Andreeff, M., & Konopleva, M. (2007). Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Blood, 109(8), 3509–3512.